Venture Life Group (LON:VLG – Get Free Report) released its earnings results on Tuesday. The company reported GBX 4.10 EPS for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.
Venture Life Group Stock Performance
Shares of LON:VLG opened at GBX 65 on Wednesday. The company has a current ratio of 4.71, a quick ratio of 1.48 and a debt-to-equity ratio of 0.82. Venture Life Group has a 1-year low of GBX 52 and a 1-year high of GBX 72. The stock has a market capitalization of £78.03 million, a P/E ratio of 14.87, a P/E/G ratio of 5.67 and a beta of 0.23. The business has a 50-day moving average price of GBX 67.48 and a two-hundred day moving average price of GBX 65.11.
About Venture Life Group
Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.
Further Reading
- Five stocks we like better than Venture Life Group
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.
